The International Bladder Cancer Network

References 

1. Grossman HB. The First and Second International Workshops on Diagnostic and Prognostic Markers in Bladder Cancer. Urol Oncol. 2000;5:183–184
   • Full Text
   • Full-Text PDF (32 KB)
   • CrossRef
2. Witjes JA, Kiemeney LA, Wheeless LL, et al. The value of histopathological prognostic factors in superficial bladder cancer: Do we need more?. Urol Oncol. 2000;5:185–190
   • Abstract
   • Full Text
   • Full-Text PDF (62 KB)
   • CrossRef
3. Reznikoff CA, Sarkar S, Jülicher KP, et al. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol. 2000;5:191–203
   • Abstract
   • Full Text
   • Full-Text PDF (555 KB)
   • CrossRef
4. Schmitz-Dräger BJ, Goebell PJ, Heydthausen M International Study Initiative on Bladder Cancer (ISBC). p53 immunohistochemistry in bladder cancer Combined analysis: a way to go?. Urol Oncol. 2000;5:204–210
   • Abstract
   • Full Text
   • Full-Text PDF (802 KB)
   • CrossRef
5. Faraggi D, Kramar A. Methodological issues associated with tumor marker development - Biostatistical aspects. Urol Oncol. 2000;5:211–213
   • Abstract
   • Full Text
   • Full-Text PDF (45 KB)
   • CrossRef
6. Taube SE, Freiberg GP. Regulatory issues related to marker development. Urol Oncol. 2000;5:214–216
   • Abstract
   • Full Text
   • Full-Text PDF (45 KB)
   • CrossRef
7. Goebell PJ, Groshen S, Schmitz-Dräger BJ, et al. The International Bladder Cancer Bank – proposal for a new study concept. Urol Oncol. 2004;22:277–284
   • Abstract
   • Full Text
   • Full-Text PDF (166 KB)
   • CrossRef
8. Goebell PJ, Groshen S, Schmitz-Dräger BJ, et al. Concepts for banking tissue in urologic oncology–the International Bladder Cancer Bank. Clin Cancer Res. 2005;11(2 Pt 1):413–415
   • MEDLINE
9. Goebell PJ, Groshen SL, Schmitz-Dräger BJ. Guidelines for development of diagnostic markers in bladder cancer. World J Urol. 2008;26:5–11
   • CrossRef